OMAN

GlaxoSmithKline Trading Services Limited.

Dublin;Ireland

  • For more information, please refer to the prescribing information or contact GlaxoSmithKline via gcc.medinfo@gsk.com
  • To report Adverse Event/s associated with the use of GSK product/s, please contact us via gulf.safety@gsk.com
  • To report quality complaint/s associated with the use of GSK product/s, please contact us via Gulf-KSA.Product-Complaints@gsk.com.
  • This is intended for healthcare professionals and patients in Oman
sotrovimab oman signoff

© 2021 GlaxoSmithKline group of companies.
or its licensor.
PM-OM-SOT-WCNT-210001 September 2021

Open cookie banner
Hide cookie banner